{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T17:47:16Z","timestamp":1776793636073,"version":"3.51.2"},"reference-count":138,"publisher":"Informa UK Limited","issue":"10","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["OncoImmunology"],"published-print":{"date-parts":[[2017,10,3]]},"DOI":"10.1080\/2162402x.2017.1315486","type":"journal-article","created":{"date-parts":[[2017,8,30]],"date-time":"2017-08-30T13:48:59Z","timestamp":1504100939000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":13,"title":["No patient left behind: The promise of immune priming with epigenetic agents"],"prefix":"10.1080","volume":"6","author":[{"given":"Corey A.","family":"Carter","sequence":"first","affiliation":[{"name":"Walter Reed National Military Medical Center, Murtha Cancer Center, Bethesda, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan T.","family":"Oronsky","sequence":"additional","affiliation":[{"name":"EpicentRx, Inc., San Diego, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Roswarski","sequence":"additional","affiliation":[{"name":"Walter Reed National Military Medical Center, Murtha Cancer Center, Bethesda, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnold L.","family":"Oronsky","sequence":"additional","affiliation":[{"name":"InterWest Partners, Menlo Park, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Oronsky","sequence":"additional","affiliation":[{"name":"CFLS Data, San Jose, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Scicinski","sequence":"additional","affiliation":[{"name":"EpicentRx, Inc., San Diego, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry","family":"Lybeck","sequence":"additional","affiliation":[{"name":",","place":["Finland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle M.","family":"Kim","sequence":"additional","affiliation":[{"name":",","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Lybeck","sequence":"additional","affiliation":[{"name":"EpicentRx, Inc., San Diego, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony R.","family":"Reid","sequence":"additional","affiliation":[{"name":",","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2017,9,15]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-189112000-00015"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.0818-9641.2003.01151.x"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0163-7258(94)90023-X"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-1116"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1177\/1535370215584936"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-140-36534"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1490019"},{"key":"e_1_3_4_9_1","first-page":"206","article-title":"Heterogeneous response of human colon cancer cells to the cytostatic and cytotoxic effects of recombinant human cytokines: Interferon-alpha, interferon-gamma, tumor necrosis factor, and interleukin-1","volume":"8","author":"Morikawa K","year":"1989","unstructured":"Morikawa K, Fidler IJ. Heterogeneous response of human colon cancer cells to the cytostatic and cytotoxic effects of recombinant human cytokines: Interferon-alpha, interferon-gamma, tumor necrosis factor, and interleukin-1. J Biol Response Mod 1989; 8:206-18; PMID:2499665","journal-title":"J Biol Response Mod"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-2776(06)90002-9"},{"key":"e_1_3_4_11_1","first-page":"283","article-title":"Targetting the PD-L1\/PD-1 axis holds promise in the treatment of malignancy","volume":"1","author":"Rosenblatt J","year":"2012","unstructured":"Rosenblatt J, Avigan D. Targetting the PD-L1\/PD-1 axis holds promise in the treatment of malignancy. Transl Cancer Res 2012; 1:283-6.","journal-title":"Transl Cancer Res"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200690"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3819"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyr184"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1101\/gr.100289.109"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.4249"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2014-1420"},{"key":"e_1_3_4_18_1","article-title":"RRx-001 An EXO-based epigenetic anti-cancer agent in phase 2 clinical trials","author":"Cabrales P","year":"2014","unstructured":"Cabrales P, Reid T, Oronsky B, Scicinski J, Chauchan D, Parker C, et\u00a0al. RRx-001 An EXO-based epigenetic anti-cancer agent in phase 2 clinical trials. ISEV International Society for Extracellular Vesicles 2014, Educational Event San Diego, Oct 26, 2014.","journal-title":"ISEV International Society for Extracellular Vesicles 2014, Educational Event San Diego"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu149"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2014.05.015"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1410626111"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.2217\/epi.09.33"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-8-56"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng1158"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrg816"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgp220"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-380866-0.60002-2"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncponc0354"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1232504"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms12128661"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2014.134"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200703157"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1604607"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.12.5.599"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/91.15.1288"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.01220-06"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/368276"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molonc.2012.09.004"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.12356"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2013.42"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv081.8"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-13611-0_3"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.432294"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2015.07.002"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.1542"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-13-0078"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2008.26.15_suppl.19036"},{"key":"e_1_3_4_48_1","unstructured":"EpicentRx unpublished data."},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni1102-991"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-015-0431-3"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0000000000000005"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.156"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00187"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.3402\/acmo.v3.27690"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1102\/1470-7330.2004.0006"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-13-144"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2012.09225.x"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/675269"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa4971"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1500596"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20010615)91:12%3c2417::AID-CNCR1276%3e3.0.CO;2-U"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.00011-08"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2013.07.007"},{"key":"e_1_3_4_64_1","first-page":"390","article-title":"Radiation-induced tumor neoantigens: Imaging and therapeutic implications","volume":"1","author":"Corso CD","year":"2011","unstructured":"Corso CD, Ali AN, Diaz R. Radiation-induced tumor neoantigens: Imaging and therapeutic implications. Am J Cancer Res 2011; 1:390-412; PMID:21969260","journal-title":"Am J Cancer Res"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717X-8-162"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms150711832"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbabio.2006.06.014"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70082-8"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4402148"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.07.056"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.07.011"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-2914"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2015-3515"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2013-LB-86"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.10290"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-006-0183-1"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2008.273"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-004-0513-0"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.12.7017"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-006-0164-4"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002371-199901000-00003"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-3091"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/926321"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.17.1.369"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.11.013"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.165.2.302"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-2776(10)05003-0"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2007.05.016"},{"key":"e_1_3_4_89_1","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.4049\/jimmunol.162.6.3256","article-title":"Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells","volume":"162","author":"Curtsinger JM","year":"1999","unstructured":"Curtsinger JM, Schmidt CS, Mondino A, Lins DC, Kedl RM, Jenkins MK, Mescher MF. Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells. J Immunol 1999; 162:3256-62; PMID:10092777","journal-title":"J Immunol"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062924"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.355"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2009.334"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604929"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-2598"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2014.00061"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4906(03)00117-0"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.109.200717"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.01121-10"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.60.0759"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1104819"},{"key":"e_1_3_4_101_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-0153"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2110"},{"key":"e_1_3_4_103_1","doi-asserted-by":"publisher","DOI":"10.7150\/thno.5658"},{"key":"e_1_3_4_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2015.12.003"},{"key":"e_1_3_4_105_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-4128"},{"key":"e_1_3_4_106_1","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/201703"},{"key":"e_1_3_4_107_1","doi-asserted-by":"publisher","DOI":"10.1038\/cgt.2011.41"},{"key":"e_1_3_4_108_1","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12382"},{"key":"e_1_3_4_109_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep13110"},{"key":"e_1_3_4_110_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0902-1039c"},{"key":"e_1_3_4_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5699(99)01520-0"},{"key":"e_1_3_4_112_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2639"},{"key":"e_1_3_4_113_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI31178"},{"key":"e_1_3_4_114_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2012.01.006"},{"key":"e_1_3_4_115_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019823"},{"key":"e_1_3_4_116_1","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1200\/jco.2013.31.15_suppl.3025","article-title":"Phase I study of the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of the oral inhibitor of indoleamine 2,3-dioxygenase (IDO1) INCB024360 in patients (pts) with advanced malignancies","volume":"31","author":"Beatty G","year":"2013","unstructured":"Beatty G, O'Dwyer P, Clark J, Shi J, Newton R, Schaub R, et\u00a0al. Phase I study of the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of the oral inhibitor of indoleamine 2,3-dioxygenase (IDO1) INCB024360 in patients (pts) with advanced malignancies. J Clin Oncol 2013; 31:Abstract 3025; PMID:23775954","journal-title":"J Clin Oncol"},{"key":"e_1_3_4_117_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri1806"},{"key":"e_1_3_4_118_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161209788453211"},{"key":"e_1_3_4_119_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-3216"},{"key":"e_1_3_4_120_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25429"},{"key":"e_1_3_4_121_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20080308"},{"key":"e_1_3_4_122_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0050038"},{"key":"e_1_3_4_123_1","doi-asserted-by":"publisher","DOI":"10.2217\/imt.12.116"},{"key":"e_1_3_4_124_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gdata.2015.05.043"},{"key":"e_1_3_4_125_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24064"},{"key":"e_1_3_4_126_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells2030545"},{"key":"e_1_3_4_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2014.03.011"},{"key":"e_1_3_4_128_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.2584"},{"key":"e_1_3_4_129_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90326-L"},{"key":"e_1_3_4_130_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.7533326"},{"key":"e_1_3_4_131_1","doi-asserted-by":"publisher","DOI":"10.1038\/35103104"},{"key":"e_1_3_4_132_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1535-6108(02)00095-8"},{"key":"e_1_3_4_133_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.274.5291.1363"},{"key":"e_1_3_4_134_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.184.3.1075"},{"key":"e_1_3_4_135_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.10.5023"},{"key":"e_1_3_4_136_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2014.06.012"},{"key":"e_1_3_4_137_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj447"},{"key":"e_1_3_4_138_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.4358"},{"key":"e_1_3_4_139_1","doi-asserted-by":"publisher","DOI":"10.2147\/ott.s7222"}],"container-title":["OncoImmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/2162402X.2017.1315486","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T01:52:19Z","timestamp":1772761939000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/2162402X.2017.1315486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,15]]},"references-count":138,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10,3]]}},"alternative-id":["10.1080\/2162402X.2017.1315486"],"URL":"https:\/\/doi.org\/10.1080\/2162402x.2017.1315486","relation":{},"ISSN":["2162-402X"],"issn-type":[{"value":"2162-402X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,15]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=koni20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=koni20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2016-07-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-03-28","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-03-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-09-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e1315486"}}